About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Brca1+
wild type
MGI:2152435
Summary 8 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Brca1tm1Bhk/Brca1+ C.129P2-Brca1tm1Bhk MGI:5517368
ht2
Brca1tm1Mak/Brca1+ either: (involves: 129P2/OlaHsd * C3H/HeJ) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1) MGI:2174686
ht3
Brca1tm1Bhk/Brca1+ involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:2174677
ht4
Brca1tm1Whl/Brca1+ involves: 129P2/OlaHsd * C57BL/6J MGI:2174688
ht5
Brca1tm1Arge/Brca1+ involves: 129S/SvEv * C57BL/6 MGI:2174675
cn6
Brca1tm1Brn/Brca1+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
involves: 129P2/OlaHsd * BALB/cJ * FVB/N MGI:3762186
cx7
Brca1tm1Bhk/Brca1+
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
C.129-Cdkn2ctm1Yxi Brca1tm1Bhk MGI:5517370
cx8
Brca1tm2Cxd/Brca1+
Tg(KRT5-E2F1)2Dgj/0
involves: 129S6/SvEvTac * C57BL/6 * SJL MGI:3836053


Genotype
MGI:5517368
ht1
Allelic
Composition
Brca1tm1Bhk/Brca1+
Genetic
Background
C.129P2-Brca1tm1Bhk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Bhk mutation (0 available); any Brca1 mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• cellular proliferation is inhibited in young and old mammary epithelial cells

endocrine/exocrine glands
• cellular proliferation is inhibited in young and old mammary epithelial cells
• less than 10% of mutants develop mammary tumors

growth/size/body
• decrease in body weight from 12 to 24 weeks of age

integument
• cellular proliferation is inhibited in young and old mammary epithelial cells
• less than 10% of mutants develop mammary tumors

neoplasm
• less than 10% of mutants develop mammary tumors




Genotype
MGI:2174686
ht2
Allelic
Composition
Brca1tm1Mak/Brca1+
Genetic
Background
either: (involves: 129P2/OlaHsd * C3H/HeJ) or (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Mak mutation (0 available); any Brca1 mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no obvious phenotype up to 11 months of age




Genotype
MGI:2174677
ht3
Allelic
Composition
Brca1tm1Bhk/Brca1+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Bhk mutation (0 available); any Brca1 mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no aberrant phenotype is seen up to 5 months of age




Genotype
MGI:2174688
ht4
Allelic
Composition
Brca1tm1Whl/Brca1+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Whl mutation (0 available); any Brca1 mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• no obvious phenotype up to 10 months of age




Genotype
MGI:2174675
ht5
Allelic
Composition
Brca1tm1Arge/Brca1+
Genetic
Background
involves: 129S/SvEv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Arge mutation (0 available); any Brca1 mutation (113 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• up to 15 months of age; in particular, no tumors are detected




Genotype
MGI:3762186
cn6
Allelic
Composition
Brca1tm1Brn/Brca1+
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
Genetic
Background
involves: 129P2/OlaHsd * BALB/cJ * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Brn mutation (2 available); any Brca1 mutation (113 available)
Tg(KRT14-cre)8Brn mutation (3 available)
Trp53tm1Brn mutation (20 available); any Trp53 mutation (237 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice develop mammary gland with a latency of 332 days

integument
• mice develop mammary gland with a latency of 332 days

endocrine/exocrine glands
• mice develop mammary gland with a latency of 332 days

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:126551




Genotype
MGI:5517370
cx7
Allelic
Composition
Brca1tm1Bhk/Brca1+
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
Genetic
Background
C.129-Cdkn2ctm1Yxi Brca1tm1Bhk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm1Bhk mutation (0 available); any Brca1 mutation (113 available)
Cdkn2ctm1Yxi mutation (1 available); any Cdkn2c mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• mammary glands of virgin females show a decrease in the expansion of luminal progenitors seen in single Cdkn2c homozygotes to normal levels but show an increase in the expansion of basal/myoepithelial cells
• 38% of mutants develop breast cancer before 1 year of age and 87% by 22 months of age
• mammary tumors show high degree of heterogeneity, increased population of CK5+ cells, loss of wild-type allele of Brca1 in CK5+ tumor cells, ERalpha negativity and invasiveness and metastasis
• mammary tumors are transformed from a luminal subtype that is seen in single Cdkn2c homozygotes into a basal-like subtype
• poorly differentiated carcinoma with squamous metaplasia

integument
• mammary glands of virgin females show a decrease in the expansion of luminal progenitors seen in single Cdkn2c homozygotes to normal levels but show an increase in the expansion of basal/myoepithelial cells
• 38% of mutants develop breast cancer before 1 year of age and 87% by 22 months of age
• mammary tumors show high degree of heterogeneity, increased population of CK5+ cells, loss of wild-type allele of Brca1 in CK5+ tumor cells, ERalpha negativity and invasiveness and metastasis
• mammary tumors are transformed from a luminal subtype that is seen in single Cdkn2c homozygotes into a basal-like subtype
• poorly differentiated carcinoma with squamous metaplasia

neoplasm
• 38% of mutants develop breast cancer before 1 year of age and 87% by 22 months of age
• mammary tumors show high degree of heterogeneity, increased population of CK5+ cells, loss of wild-type allele of Brca1 in CK5+ tumor cells, ERalpha negativity and invasiveness and metastasis
• mammary tumors are transformed from a luminal subtype that is seen in single Cdkn2c homozygotes into a basal-like subtype
• poorly differentiated carcinoma with squamous metaplasia
• 4 of 13 (31%) mammary tumors metastasize to the lung and blood vessels after 1 year of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:198018




Genotype
MGI:3836053
cx8
Allelic
Composition
Brca1tm2Cxd/Brca1+
Tg(KRT5-E2F1)2Dgj/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Brca1tm2Cxd mutation (3 available); any Brca1 mutation (113 available)
Tg(KRT5-E2F1)2Dgj mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mutants develop tumors after 1 year of age and by 70 weeks, 50% of mutants have tumors
• majority of tumors occur in the skin
• majority of tumors are squamous cell carcinoma

integument
• increase in basal keratinocyte proliferation
• mutants exhibit increased epidermal proliferation and apoptosis
• majority of tumors occur in the skin

cellular
• increase in basal keratinocyte proliferation





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory